| Literature DB >> 35309931 |
Tomoaki Hishida1,2, Eric Vazquez-Ferrer1, Yuriko Hishida-Nozaki1, Yuto Takemoto3, Fumiyuki Hatanaka1, Kei Yoshida3, Javier Prieto1, Sanjeeb Kumar Sahu1, Yuta Takahashi1, Pradeep Reddy1, David D O'Keefe1, Concepcion Rodriguez Esteban1, Paul S Knoepfler4, Estrella Nuñez Delicado5, Antoni Castells6, Josep M Campistol6, Ryuji Kato3, Hiroshi Nakagawa7,8, Juan Carlos Izpisua Belmonte1.
Abstract
It is widely believed that cellular senescence plays a critical role in both aging and cancer, and that senescence is a fundamental, permanent growth arrest that somatic cells cannot avoid. Here we show that Myc plays an important role in self-renewal of esophageal epithelial cells, contributing to their resistance to cellular senescence. Myc is homogeneously expressed in basal cells of the esophageal epithelium and Myc positively regulates their self-renewal by maintaining their undifferentiated state. Indeed, Myc knockout induced a loss of the undifferentiated state of esophageal epithelial cells resulting in cellular senescence while forced MYC expression promoted oncogenic cell proliferation. A superoxide scavenger counteracted Myc knockout-induced senescence, therefore suggesting that a mitochondrial superoxide takes part in inducing senescence. Taken together, these analyses reveal extremely low levels of cellular senescence and senescence-associated phenotypes in the esophageal epithelium, as well as a critical role for Myc in self-renewal of basal cells in this organ. This provides new avenues for studying and understanding the links between stemness and resistance to cellular senescence.Entities:
Keywords: MYC; aging; cancer; mitochondria highlights; senescence
Year: 2022 PMID: 35309931 PMCID: PMC8931341 DOI: 10.3389/fcell.2022.786031
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
FIGURE 1No visible senescence of esophageal epithelial cells expressing pluripotency factors. (A) Representative immunofluorescent pictures of Ki67 (green) staining and H&E staining in the esophagus and small intestine for young (3 months old), old (22 months old) and LMNA G609G HGPS mouse model (3 months old). Scale bars, 100 μm. (B) Proliferative index of the esophagus and small intestine. We quantified Ki67+ cells in the esophagus and small intestine from three mice for each group. Data represent the mean with SD. ns = non-significant, *p < 0.01, **p < 0.001, ***p < 0.0001. (C) SA-βgal staining in the esophagus, small intestine and kidney for both young (3 months old) and LMNA G609G HGPS mouse models (3 months old). Scale bars, 100 μm. (D) qPCR analysis for aging markers. SI: Small Intestine. Data represent the mean with SE (n = 3). (E) qPCR analysis for the esophagus and the skin from young and old mice. Krt1 and krt13 were used as specific keratins for the skin and the esophagus, respectively. Data represent the mean with SE (n = 3). (F) Western blotting for pluripotency factors. Epithelial cells were isolated from the indicated tissues and cultured for 1 week before cell lysate preparation.
FIGURE 4Mitochondrial analysis in Myc cdKO mEPCs. (A) Mitochondrial quantity and activity in Myc cdKO mEPCs treated for 2 days. Data represent the mean with SD (n = 3). *p < 0.0001. (B) Mitochondrial superoxide levels in 4OH-treaed cells. Data represent the mean with SD (n = 3). *p < 0.0001. (C) Rescue effect of Mitotempo. Left, representative image of each condition. Right, quantification of total cell number. Data represent the mean with SE. ns = non-significant, *p < 0.05, **p < 0.0001. (D) Rescue effect of Mitotempo on cell size. *p < 0.0001. (E) Histogram of the cell size distribution. (F) qPCR analysis for Mitotempo-rescued cells. Data represent the mean with SD (n = 3). (G) Proposed model of Myc function supporting self-renewal of the esophageal basal cells.
FIGURE 2Loss-of-function and gain-of-function of Myc in the esophagus. (A) IHC for GFP on paraffin-embedded sections of the esophagus and forestomach from GFP-Myc Knock-in (KI) mice. Scale bars, 100 μm. Two mice were analyzed. (B) IHC image of MYC staining for the human esophagus and skin. MYC is largely expressed in esophageal basal layer. The data were kindly provided by the Protein Atlas Project publicly available (www.proteinatlas.org). (C) Schematic representation of Sox2+ cell-specific Myc conditional double knockout mice, Sox2 CreER/WT; cMyc Flox/Flox; nMyc Flox/Flox; ROSA (Myc cdKO). GFP can be used for lineage tracing purpose. (D) H&E staining for esophagi from Myc cdKO mice treated with TAM. Two mice were analyzed for each condition. (E) Cell size of esophageal basal cells. Two mice were used for each condition. Data represent the mean with SE. *p < 0.05, **p < 0.0001. (F) Clonogenic colony-forming assays. After cell isolation, 2,500 live cells were seeded per well in 6-well plate in ADCY medium. Twelve days after seeding, the cells were stained with Leishman’s stain to count the number of colonies. Each culture was derived from each indicated mice. Left, representative image of each condition. Right, quantification of colony number. Data represent the mean with SD (n = 3). (G) Schematic representation of Sox2 CreER/WT; tetO-MYC; ROSA LSL-rtTA-GFP/LSL-Luc mouse. TAM treatment eliminates STOP cassette in front of rtTA-IRES-GFP in ROSA26 locus, which can activate transgenic MYC expression in a tetracycline- or doxycycline (Dox)-dependent manner. GFP expression allows for lineage tracing. The mice were collected 10 days after 2-days TAM treatment. Dox was administered to the mice in their drinking water (0.5 mg/ml). (H,I) H&E (H) and IHCs (I) on paraffin-embedded sections of the indicated tissues corrected from SMPWT/WT. Three mice were analyzed. Scale bars, 100 μm. (J) Inflammation along with tumor invasion in forestomach. Scale bars, 100 μm.
FIGURE 3Requirement of Myc for preserving self-renewal of esophageal epithelial cells. (A) Genotyping to confirm Myc knockout. The cells were treated with 0.1 μM 4OH for 3 days and lysed for genomic DNA purification. PCR reactions were performed using purified genomic DNA for WT, Flox and deleted (Δ) alleles of c-myc and N-Myc. (B) Live-imaging of Myc cdKO mEPCs. Left, image acquisition scheme. Right, image-based cell count. (C) Image of untreated and the Myc cdKO mEPCs treated with 4OH for 9 days. White arrow indicates multinuclear cells. (D) SA-βgal staining in Myc cdKO mEPCs treated with 4OH for 9 days. Data represent the mean with SE (n = 6). *p < 0.0001. (E) Quantification of total cell number in (D). Data represent the mean with SE (n = 6). *p < 0.0001. (F) Quantification of SA-βgal-positive cells in (D). Data represent the mean with SE (n = 6). *p < 0.0001. (G) Western blotting for Myc cdKO mEPCs treated with 4OH for 6 days. (H) Nanostring-based gene expression analysis. Myc cdKO mEPCs were treated with 4OH and samples were collected at the indicated time-points. RNAs were isolated and subjected to Nanostring RNA detection. (I) Cell cycle analysis of Myc cdKO mEPCs by FACS.